Pegloticase: In Treatment-Refractory Chronic Gout

Author： Lyseng-Williamson Katherine A.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.71, Iss.16, 2011-11, pp. : 2179-2192

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pegloticase and the patient with treatment-failure gout

By Dave Amish J   Kelly Victoria M   Krishnan Eswar  

Expert Review of Clinical Pharmacology, Vol. 5, Iss. 5, 2012-09 ,pp. : 501-508

Informa Healthcare

Access to resources Recommend Favorite

Basiliximab may be beneficial for treatment-refractory chronic atopic dermatitis

By  

Inpharma, Vol. 1, Iss. 1305, 2001-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Eltrombopag: A Review of its Use in Treatment-Refractory Chronic Primary Immune Thrombocytopenia

By Garnock-Jones Karly P.  

Drugs, Vol. 71, Iss. 10, 2011-07 ,pp. : 1333-1353

Adis International

Access to resources Recommend Favorite

Pharmacotherapy for treatment-refractory schizophrenia

By Van Sant Scott P   Buckley Peter F  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 3, 2011-02 ,pp. : 411-434

Informa Healthcare

Access to resources Recommend Favorite

Tacrolimus superior for treatment-refractory RA

By  

Inpharma, Vol. 1, Iss. 1570, 2007-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite